# Vogt-Koyanagi-Harada Syndrome: A Case Report

## TL;DR

This paper presents a case of Vogt-Koyanagi-Harada Syndrome, an autoimmune condition affecting vision and hearing, and highlights the importance of early diagnosis and treatment.

## Contribution

The paper contributes a detailed case report of a 48-year-old female with VKH disease and her treatment outcomes.

## Key findings

- The patient exhibited symptoms of anterior uveitis and developed glaucoma.
- Treatment with systemic steroids and intratympanic injections showed positive biochemical indicators of reduced inflammation.
- VKH is linked to genetic factors and is more prevalent in East Asia and India.

## Abstract

Vogt-Koyanagi-Harada disease (VKH) is a neurological disorder that impacts vision and hearing by causing the immune system to attack melanocytes. Symptoms of the condition include flu-like symptoms, eye pain, headache, and dizziness, which may progress to vitiligo and hearing impairment. The diagnostic criteria include ocular involvement, generalized choroiditis, tinnitus, meningitis, and skin depigmentation. The treatment includes corticosteroids and immunosuppressive drugs. VKH is believed to be an autoimmune condition, possibly triggered by hereditary factors and cross-reactivity with cytomegalovirus. VKH is common in East Asia and India and has a genetic link to certain alleles. Inflammation generated by Th1 in melanocytes results in the production of granulomas. An analysis of a 48-year-old female with VKH disease revealed symptoms of anterior uveitis and subsequent glaucoma. The treatment involved the administration of systemic steroids and intratympanic steroid injections. Biochemical indicators showed signs of inflammation. Timely identification and therapy are essential for managing VKH. Further research is necessary to enhance outcomes for patients with VKH disease.